Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Verrica Pharmaceuticals Inc. is not a good value stock. Verrica Pharmaceuticals Inc. is not a good growth stock. Verrica Pharmaceuticals Inc. is a mediocre stock to choose.
Log in to see more information.
Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company, which engage...
VRCA Fundamental Data by TradingView

News

Pharming Group (OTCMKTS:PHGUF) versus Verrica Pharmaceuticals (NASDAQ:VRCA) Head-To-Head Survey
Pharming Group (OTCMKTS:PHGUF) versus Verrica Pharmaceuticals (NASDAQ:VRCA) Head-To-Head Survey

Zolmax Verrica Pharmaceuticals (NASDAQ:VRCA - Get Free Report) and Pharming Group (OTCMKTS:PHGUF - Get Free Report) are both medical companies, but which is the better investment? We will compare the two...\n more…

Critical Comparison: Pharming Group (OTCMKTS:PHGUF) vs. Verrica Pharmaceuticals (NASDAQ:VRCA)
Critical Comparison: Pharming Group (OTCMKTS:PHGUF) vs. Verrica Pharmaceuticals (NASDAQ:VRCA)

Ticker Report Pharming Group (OTCMKTS:PHGUF - Get Free Report) and Verrica Pharmaceuticals (NASDAQ:VRCA - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two...\n more…

Verrica Pharmaceuticals Finalizes Agreements with Former Officer
Verrica Pharmaceuticals Finalizes Agreements with Former Officer

TipRanks Financial Blog Verrica Pharmaceuticals ( ($VRCA) ) has issued an announcement. Verrica Pharmaceuticals Inc. has finalized agreements with Joe Bonaccorso, their former Chief Commer...\n more…

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York

Globe Newswire WEST CHESTER, Pa., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ( Verrica or the Company ) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin...\n more…

Royal Bank of Canada Trims Verrica Pharmaceuticals (NASDAQ:VRCA) Target Price to $13.00
Royal Bank of Canada Trims Verrica Pharmaceuticals (NASDAQ:VRCA) Target Price to $13.00

Ticker Report Verrica Pharmaceuticals (NASDAQ:VRCA - Free Report) had its price objective cut by Royal Bank of Canada from $14.00 to $13.00 in a report released on Thursday morning, Benzinga reports. They...\n more…

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Simply Wall St Verrica Pharmaceuticals Inc. ( NASDAQ:VRCA ) investors will be delighted, with the company turning in some strong...\n more…